Concavit Capsules

Country: Malta

Language: English

Source: Medicines Authority

Active ingredient:

CALCIUM PANTOTHENATE, ASCORBIC ACID, COLECALCIFEROL, DL, ALFA, TOCOPHERYL ACETATE, NICOTINAMIDE, THIAMINE MONONITRATE, PYRIDOXINE HYDROCHLORIDE, RETINOL PALMITATE, RIBOFLAVIN

Available from:

Wallace Manufacturing Chemists Limited 51-53 Stert Street, Abingdon, OX14 3JF, United Kingdom

ATC code:

A11BA

INN (International Name):

CALCIUM PANTOTHENATE 5 mg ASCORBIC ACID 40 mg COLECALCIFEROL 500 IU DL-ALFA-TOCOPHERYL ACETATE 2 IU NICOTINAMIDE 20 mg THIAMINE MONONITRATE 2.5 mg PYRIDOXINE HYDROCHLORIDE 1 mg RETINOL PALMITATE 5000 IU RIBOFLAVIN 2.5 mg

Pharmaceutical form:

SOFT CAPSULE

Composition:

CALCIUM PANTOTHENATE 5 mg ASCORBIC ACID 40 mg COLECALCIFEROL 500 IU DL-ALFA-TOCOPHERYL ACETATE 2 IU NICOTINAMIDE 20 mg THIAMINE MONONITRATE 2.5 mg PYRIDOXINE HYDROCHLORIDE 1 mg RETINOL PALMITATE 5000 IU RIBOFLAVIN 2.5 mg

Prescription type:

OTC

Therapeutic area:

VITAMINS

Authorization status:

Withdrawn

Authorization date:

2006-04-13

Patient Information leaflet

Concavit Capsules 

Each Capsule contains: - 
Vitamin A BP 
5000.00 iu 
Calciferol BP 
500.00 iu 
Ascorbic Acid BP 
40.00 mg 
Thiamine Mononitrate BP 
2.50 mg 
Riboflavine BP 
2.50 mg 
Pyridoxine Hydrochloride BP  1.00 mg 
Nicotinamide BP 
20.00 mg  
Calcium Pantothenate BP 
5.00 mg 
dl-
α -Tocopheryl Acetate BP  2.00 iu 

In addition the capsules also contain: Soya Bean Oil, Fat 
mixture, Soya Lecithin, Gelatin, Glycerin, Sorbitol, 
Hydroxybenzoates (Ethyl and Propyl), Ponceau 4R (E124) 
and water. 

Concavit capsules are available in packs of 25 and 100. 

Concavit is an oral vitamin supplement. 

The product licence holder is Wallace Manufacturing 
Chemists Ltd., 52 Queen Anne Street, London W1M 9LA, 
England and the capsules are manufactured by Cardinal 
Health, Frankland Road, Blagrove Estate, Swindon, Wiltshire 
SN5 8YS, England. 

Concavit is intended as a multiple vitamin supplement in 
situations of special dietary need. It is not intended for
the 
correction of specific vitamin deficiencies. 

BEFORE YOU USE CONCAVIT 
Do not use Concavit to treat vitamin deficiencies caused by 
inability to absorb the vitamin(s) orally. 

Do not use Concavit if: 
•  You are hypersensitive to any of the ingredients 
•  You have a history of high levels of Vitamins A or D 
•  You have bone tumours 
•  You have elevated blood calcium levels. 
•  You have abnormal metabolic sensitivity to vitamin D 

Do not take Vitamin A supplements if you are pregnant or 
likely to become pregnant except on the advice
of your doctor 
or antenatal clinic. 

PRECAUTIONS FOR THE USE OF CONCAVIT 
Do not exceed the stated dose. 

INTERACTIONS WITH OTHER MEDICINE 
Concavit may react with other medicines you are taking. 
Concavit contains a range of Vitamins and each can affect and 
in turn be affected by other medicines you are ta

Summary of Product characteristics

Page 1 of 4 
SUMMARY OF PRODUCT CHARACTERISTICS 

1. 
TRADE NAME OF THE MEDICINAL PRODUCT 
Concavit Capsules 

2. 
QUALITATIVE AND QUANTITATIVE COMPOSITION 
_ _
_Each Capsule contains: - _

Vitamin A BP 
  5000.00 iu 
Calciferol BP 
  500.00 iu 
Ascorbic Acid BP 
  40.00 mg 
Thiamine Mononitrate BP 
  2.50 mg 
Riboflavine BP  
  2.50 mg 
Pyridoxine Hydrochloride BP 
  1.00 mg 
Nicotinamide BP 
  20.00 mg  
Calcium Pantothenate BP 
  5.00 mg 
dl- -Tocopheryl Acetate BP 
  2.00 iu 

3. PHARMACEUTICAL 
FORM 
 Soft Gelatine Capsules 

CLINICAL PARTICULARS 

4.1. THERAPEUTIC 
INDICATIONS 
As a supplement of multiple vitamins in situations of
special dietary need. Not suitable for 
the correction of specific vitamin deficiencies. 

4.2. 
POSOLOGY AND METHOD OF ADMINISTRATION 
Adults, The Elderly and Children - 1 capsule daily 

4.3. CONTRA-INDICATIONS 
•  Oral administration in the treatment of deficiency state
in malabsorption syndromes. 
•  Hypersensitivity to any of the ingredients. 
•  History of hypervitaminoses A or D. 
•  Sarcoidosis 
•  Hypercalcaemia 
•  Abnormal metabolic sensitivity to Vitamin D. 
•  Do not take Vitamin A supplements if you are pregnant or
likely to become pregnant 
except on the advice of a doctor or antenatal clinic. 

4.4. 
SPECIAL WARNINGS AND PRECAUTIONS FOR USE 
There are serious risks of developing hypercalcaemia
when calcium salts or thiazides are co-
administered. Serum calcium, phosphate, alkaline phosphatase, liver
function tests and 
magnesium should be monitored when indicated. 

Page 2 of 4 
Absorption of Vitamin A is
reduced in cystic fibrosis, hepatic diseases, pancreatic 
dysfunction and in patients with intestinal infections. 

The use of Vitamin A in renal
diseases requires extreme caution. 

4.5. 
INTERACTIONS WITH OTHER MEDICAMENTS AND